Recent findings have revealed that in KEAP1-deficient and immunotherapy-resistant HNSCC models, induction of NQO1 can trigger ferroptosis while simultaneously initiating antitumor immune activation. This evidence concerns the gene KEAP1 and head and neck squamous cell carcinoma.